Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-22

FDA Approved: SUMATRIPTAN SUCCINATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application from Sun Pharmaceutical Industries to bring a generic sumatriptan succinate product to market for the acute treatmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sumatriptan succinate (Sumatriptan succinate)

Snippet

SUPPL AP for SUMATRIPTAN SUCCINATE (SUMATRIPTAN SUCCINATE)